INGRAM ROBERT ALEXANDER 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 2, 2022
Insider Transaction Report
Form 4
INGRAM ROBERT ALEXANDER
Director
Transactions
- Award
Common Stock
2022-05-31$9.31/sh+2,078$19,346→ 82,138 total
Footnotes (1)
- [F1]Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $20,000, prorated to $19,347.83 based on the increase in the annual retainer fee effective April 18, 2022.